Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $116.93 | $26.32 | 344.27% | 220.62x | 55.65x | 14.83x | 17.91x | 1.60x | $106.92M | 0.87% | $705.78M | 6.70 | $12.54B | 1,598.26 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $24.87 | $8.95 | 177.82% | 118.43x | 57.84x | 7.00x | 14.17x | 1.02x | $39.15M | 1.21% | $220.58M | 1.69 | $3.21B | 70.62 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $236.56 | $86.80 | 172.52% | 38.78x | 34.87x | 6.58x | 23.38x | 1.37x | $793.95M | 2.51% | $1.35B | 10.14 | $32.93B | 27.92 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.80 | $18.96 | 320.85% | 74.58x | 68.27x | 7.36x | 9.52x | 1.90x | $182.84M | 2.95% | $654.15M | 8.43 | $6.06B | 50.52 | ||
| HALO | HALOZYME THERAPEUTICS INC | $106.92 | $74.33 | 43.84% | 30.03x | 11.84x | 7.54x | 84.54x | 0.61x | $806.22M | 6.43% | $143.54M | 1.22 | $14.12B | 19.65 | ||
| RPRX | ROYALTY PHARMA PLC | $61.92 | $39.42 | 57.07% | 32.94x | 11.56x | 10.87x | 3.64x | 0.67x | $2.92B | 10.61% | $9.79B | 21.99 | $43.75B | 37.20 | ||
| VCEL | VERICEL CORP | $41.18 | $8.75 | 370.48% | 85.79x | 73.58x | 6.87x | 5.70x | 2.11x | $61.66M | 2.93% | $370.04M | 7.25 | $2.08B | 47.13 | ||
| KRYS | KRYSTAL BIOTECH INC | $357.46 | $92.28 | 287.36% | 43.22x | 45.80x | 23.96x | 7.78x | 2.29x | $257.78M | 2.44% | $1.36B | 46.03 | $10.16B | 43.56 | ||
| TGTX | TG THERAPEUTICS INC | $55.72 | $24.54 | 127.01% | 18.09x | 56.07x | 9.88x | 14.12x | 2.01x | $17.39M | 0.22% | $604.08M | 4.26 | $8.80B | 63.19 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $65.29 | $20.62 | 216.62% | 171.82x | 22.42x | 3.71x | 2.00x | 1.13x | $738.18M | 5.84% | $6.32B | 32.68 | $15.95B | 41.36 | ||
| TECH | BIO-TECHNE CORP | $72.47 | $17.94 | 304.00% | 61.94x | 34.71x | 9.30x | 5.39x | 1.95x | $263.22M | 2.33% | $2.11B | 13.52 | $11.39B | 32.76 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.85 | $8.33 | 42.21% | 12.47x | 10.89x | 5.15x | 3.23x | 1.09x | $82.01M | 11.70% | $217.65M | 3.68 | $559.87M | 7.24 | ||
| ADMA | ADMA BIOLOGICS INC | $9.48 | $7.64 | 24.09% | 13.17x | 11.92x | 4.22x | 5.20x | 0.77x | $116.47M | 5.38% | $408.21M | 1.79 | $2.19B | 9.38 | ||
| EXEL | EXELIXIS INC | $55.26 | $32.80 | 68.46% | 16.80x | 16.73x | 5.69x | 7.43x | 1.11x | $1.17B | 8.46% | $1.84B | 7.35 | $13.58B | 12.48 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.21 | $6.51 | -81.40% | 8.64x | -4.09x | 1.49x | 1.59x | 0.07x | $19.58M | 27.93% | $44.20M | 0.76 | $21.73M | 2.84 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $284.52 | $94.09 | 202.41% | 28.25x | 30.12x | 19.65x | 5.86x | 2.14x | $130.62M | 2.29% | $967.52M | 48.22 | $5.80B | 20.78 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $251.10 | $194.87 | 28.85% | 16.45x | 9.83x | 3.45x | 3.39x | 0.69x | $1.62B | 10.21% | $4.80B | 75.98 | $19.08B | 11.80 | ||
| MDXG | MIMEDX GROUP INC | $4.51 | $1.56 | 189.00% | 112.75x | -32.15x | 1.88x | 3.04x | 1.07x | $44.50M | 6.67% | $216.00M | 1.46 | $538.75M | 23.62 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $547.55 | $166.61 | 228.64% | 31.60x | 28.48x | 11.04x | 6.85x | 2.25x | $3.80B | 2.73% | $20.25B | 79.81 | $134.62B | 24.46 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $807.71 | $467.03 | 72.95% | 19.26x | 14.48x | 5.34x | 2.62x | 1.03x | $3.76B | 4.53% | $31.71B | 308.48 | $83.41B | 14.51 | ||
| UTHR | UNITED THERAPEUTICS CORP | $527.91 | $209.74 | 151.69% | 17.46x | 19.71x | 7.13x | 3.54x | 3.02x | $1.09B | 4.86% | $6.40B | 150.24 | $20.84B | 12.43 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.87 | $32.95 | 21.01% | 12.70x | 9.56x | 2.41x | 2.32x | 0.76x | $354.90M | 15.36% | $999.24M | 17.25 | $1.93B | 6.88 | ||
| INCY | INCYTE CORP | $127.74 | $64.50 | 98.06% | 15.73x | 36.03x | 4.40x | 4.08x | 1.77x | $1.92B | 7.50% | $6.34B | 31.66 | $21.94B | 10.61 | ||
| VCYT | VERACYTE INC | $45.25 | $7.41 | 510.35% | 31.42x | 43.28x | 6.44x | 2.62x | 124.99x | $165.99M | 4.59% | $1.39B | 17.36 | $3.38B | 24.17 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.